Pityrosporum species as a cause of allergy and infection

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 5, 1999, Pages 413-419

  Faergemann, Jan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ALLERGY; ATOPIC DERMATITIS; DERMATOMYCOSIS; FOLLICULITIS; HOST RESISTANCE; HUMAN; IMMUNOREACTIVITY; INFECTION RESISTANCE; NONHUMAN; PITYROSPORUM OVALE; PRICK TEST; PRIORITY JOURNAL; REVIEW; SEBORRHEIC DERMATITIS; TINEA VERSICOLOR; VIRULENCE;

ADULT; AGED; AGED, 80 AND OVER; CHILD; DERMATITIS, ATOPIC; FOLLICULITIS; HUMANS; MALASSEZIA; TINEA VERSICOLOR;

EID: 0033020929     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00089.x     Document Type: Review

References (59)

1. Guého E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek 1996;69:337-355.
2. Guillot J, Guého E, Lesourd M, Midgley G, Chėvrier G, Dupont B. Identification of Malassezia species · a practical approach. J Mycol Med 1996;6:103-110.
3. Faergemann J. Lipophilic yeasts in skin disease. Semin Dermatol 1985;4:173-184.
4. Faergemann J. Pityrosporum yeasts - what's new? Mycoses 1997;40 Suppl 1:19-32.
5. Faergemann J. Pityrosporum infections. In: Elewski BE, editor. Cutaneous fungal infections. New York: Igaku-Shoin, 1991:69-83.
6. Faergemann J. Tinea versicolor (pityriasis versicolor). In: Demis DJ, editor. Clinical dermatology. Philadelphia: Lippincott-Raven, 1995:1-9.
7. Jones HE. Ketoconazole today. A review of clinical experience. Manchester: ADIS Press, 1987.
8. Delescluse J. Itraconazole in tinea versicolor. A review. J Am Acad Dermatol 1990;23:551-554.
9. Faergemann J. Treatment of pityriasis versicolor with a single dose of fluconazole. Acta Derm Venereol (Stockh) 1992;72:74-75.
10. Faergemann J, Djärv L. Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis 1982;30:542-545:
11. Faergemann J. Antibodies to Pityrosporum orbiculare in patients with tinea versicolor and controls of various ages. J Invest Dermatol 1983;80:133-135.
12. Bergbrant I-M, Faergemann J. The role of Pityrosporum ovale in seborrheic dermatitis. Semin Dermatol 1990;9:262-268.
13. Da Mert GJ, Kirkpatrick CH, Sohnle PG. Comparison of antibody response in chronic mucocutaneous candidiasis and tinea versicolor. Int Arch Allergy Appl Immunol 1980;63:69-76.
14. Wu YC, Chen KT. Humoral immunity in patients with tinea versicolor. J Dermatol 1987;12:161-166.
15. Sohnle PG, Collins-Lech C. Relative antigenicity of P. orbiculare and C. albicans. J Invest Dermatol 1980;75:279-283.
16. Sohnle PG, Collins-Lech C. Analysis of the lymphocyte transformation response to Pityrosporum orbiculare in patients wit tinea versicolor. Clin Exp Immunol 1982;49:559-564.
17. Wu C, Chen KT. Lymphocyte proliferation to crude extract of Pityrosporum species and natural killer activity in tinea versicolor. J Med Assoc Thailand 1985;70 Suppl 3:45.
18. Ashbee HR, Ingham E, Holland KT, Cunliffe WJ. Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Exp Dermatol 1994;3:106-112.
19. Kesavan S, Walters CE, Holland KT, Ingham E. The effects of Malassezia on pro-inflammatory cytokine production by human peripheral blond mononuclear cells in vitro. Med Mycol 1998;36:97-106.
20. Guého E, Boekhout T, Ashbee HR, Guillot J, van Belkum A, Faergemann J. The role of Malassezia species in the ecology of human skin and as pathogens. Med Mycol 1998;36 Suppl 1:220-229.
21. Ingham E, Cunningham AC. Malassezia furfur. J Med Vet Mycol 1993;31:265-288.
22. Richardson MD, Shankland GS. Enhanced phagocytosis and intracellular killing of Pityrosporum ovale by human neutrophils after exposure to ketoconazole is correlated to changes of the yeast cell surface. Mycoses 1991;34:29-33.
23. Sohnle PG, Collins-Lech C. Activation of complement by Pityrosporum orbiculare. J Invest Dermatol 1983;80:93-97.
24. Scheynius A, Faergemann J, Forsum U, et al. Phenotypic characterisation in situ of inflammatory cells in pityriasis (tinea) versicolor. Acta Derm Venereol (Stockh) 1984;64:473-479.
25. Back O, Faergemann J, Hörnqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol 1985;12:56-61.
26. Faergemann J, Johansson S, Bäck O, et al. An immunologic and cultural study of Pityrosporum folliculitis. J Am Acad Dermatol 1986;14:429-433.
27. Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 1984;111:235-242.
28. Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol 1986;114:695-700.
29. Bergbrant I-M. Seborrhoeic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies. Acta Derm Venereol (Stockh) 1991;(Suppl 167).
30. Bergbrant I-M, Johansson S, Rubbins D, Scheynius A, Faergemann J, Söderström T. An immunological study in patients with seborrhoeic dermatitis. Clin Exp Dermatol 1991;16:331-338.
31. Midgley G, Hay RJ. Serological responses to Pityrosporum (Malassezia) in seborrhoeic dermatitis demonstrated by ELISA and Western blotting. Bull Soc Fr Mycol Med 1988;17:267-276.
32. Ashbee HR, Fruin A, Holland KT, Cunliffe WJ, Ingham E. Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Exp Darmatol 1994;3:227-233.
33. Wikler JR, Trago E, de Haan P, Nieboer C. Cell-mediated deficiency to Pityrosporum orbiculare in patients with seborrhoeic dermatitis. Abstracts of the ESDR-JSID-SID Tricontinental Meeting, Washington, DC, 26-30 April 1989.
34. Neuber K, Kröger S, Gruseck E, Abeck D, Ring J. Effects of Pityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis and cytokine (IL-2, IL-10, IFN-γ) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis. Arch Dermatol Res 1996;288:532-536.
35. Clemmensen OJ, Hjorth N. Treatment of dermatitis of the head and neck with ketoconazole in patients with a type I sensitivity to Pityrosporum orbiculare. Semin Dermatol 1983;2:26-29.
36. Waersted A, Hjorth N. Pityrosporum orbiculare - a pathogenic factor in atopic dermatitis of the face, scalp and neck? Acta Derm Venereol (Stockh) 1985;(Suppl 114):146-148.
37. Kieffer M, Bergbrant I-M, Faergemann J, et al. Immune reactions to Pityrosporum ovale in adult patients with atopic dermatitis and seborrhoeic dermatitis. J Am Acad Dermatol 1990;22:739-742.
38. Rokugo M, Tagami H, Usuba Y, Tomota Y. Contact sensitivity to Pityrosporum ovale in patients with atopic dermatitis. Arch Dermatol 1990;126:627-632.
39. Broberg A, Faergemann J, Johansson S, Johansson SGO, Strannegård I-L. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol (Stockh) 1992;72:187-192.
40. Johansson S, Karlström K. IgE-binding components in Pityrosporum orbiculare identified by an immunoblotting technique. Acta Derm Venereol (Stockh) 1991;71:11-16.
41. Wessels MW, Doekes G, van Ieperen-Van Diejk AG, Koers WJ, Young E. IgE antibodies to Pityrosporum ovale in atopic dermatitis. Br J Dermatol 1991;125:227-232.
42. Jensen-Jarolim E, Poulsen LK, With H, Kieffer M, Ottevanger V, Skov PS. Atopic dermatitis of the face, scalp, and neck: type I reaction to the yeast Pityrosporum ovale? J Allergy Clin Immunol 1992;89:44-50.
43. Doekes G, van Ieperen-Van Diejk AG. Allergens of Pityrosporum ovale and Candida albicans. I. Cross-reactivity of IgE-binding components. Allergy 1991;48:394-400.
44. Doekes G, Kaal MJH, van Ieperen-Van Diejk AG. Allergens of Pityrosporum ovale and Candida albicans. II. Physicochemical characterization. Allergy 1993;48:401-408.
45. Zagari A, Härfast B, Johansson S, Johansson SGO, Scheynius A. Identification of allergen components of the opportunistic yeast Pityrosporum orbiculare by monoclonal antibodies. Allergy 1994;49:50-56.
46. Huang X, Johansson SGO, Zargari A, Nordvall SL. Allergen cross-reactivity between Pityrosporum orbiculare and Candida albicans. Allergy 1995;50:648-656.
47. Kröger S, Neuber K, Gruseck E, Ring J, Abeck D. Pityrosporum ovale extracts increase interleukin-4, interleukin-10 and IgE synthesis in patients with atopic eczema. Acta Derm Venereol (Stockh) 1995;75:357-360.
48. Zargari A, Doekes G, van Ieperen-Van Diejk AG, Landberg E, Härfast B, Scheynius A. Influence of culture period on the allergenic composition of Pityrosporum orbiculare extracts. Clin Exp Allergy 1995;25:1235-1245.
49. Tengvall Linder M, Johansson S, Zargari A, et al. Clin Exp Allergy 1996;26:1286-1297.
50. Schmidt M, Zargari A, Holt P, et al. The complete cDNA sequence and expression of the first major allergenic protein of Malassezia furfur, Mal f 1. Eur J Biochem 1997;246:181-185.
51. Savolainen J, Broberg A. Cross-reacting IgE antibodies to Pityrosporum ovale and Candida albicans in atopic children. Clin Exp Allergy 1992;22:469-474.
52. Lintu P, Savolainen J, Kalimo K. IgE antibodies to protein and mannan antigens of Pityrosporum ovale in atopic dermatitis patients. Clin Exp Allergy 1997;27:87-95.
53. Zargari A, Emilson A, Halldén G, Johansson S, Scheynius A. Cell surface expression of two major yeast allergens in the Pityrosporum genus. Clin Exp Allergy 1997;27:584-592.
54. Savolainen J, Lammintausta K, Kalimo K, Viander M. Candida albicans and atopic dermatitis. Clin Exp Allergy 1993;23:332-339.
55. Yasueda H, Hashida-Okado T, Saito A, et al. Identification and cloning of two novel allergens from the lipophilic yeast, Malassezia furfur. Biochem Biophys Res Commun 1998;248:240-244.
56. Bäck O, Scheynius A, Johansson SGO. Ketoconazole in atopic dermatitis; therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res 1995;287:448-451.
57. Kolmer H, Taketomi A, Hazen KC, Hughs E, Wilson BB, Platts-Mills AE. Effect of combined antibacterial and antifungal treatment in severe atopic dermatitis. J Allergy Clin Immunol 1996;98:702-707.
58. White I, Blatchford I. The treatment of secondary bacterial infections in atopic eczema with miconazole plus hydrocortisone. Br J Clin Pract 1983;222:215-216.
59. Broberg A, Faergemann J. Topical antimycotic treatment of atopic dermatitis in the head/neck area. Acta Derm Venereol (Stockh) 1995;75:46-49.